A virus pseudotyped with glycoprotein of vesicular stomatitis virus (VSV-G) can enter various cell types at a relatively high titer. We observed that the amount of viral antigen from VSV-G pseudotyped human immunodeficiency virus type 1 (HIV-1) producing cells was much higher than that from their non-pseudotyped counterparts. This enhanced viral antigen production was not observed when we used HIV-1 pol mutant, viral enzyme inhibitors, HIV Env protein, or VSV-G fusion defective mutants. The transfection experiment using GFP-expressing virus showed timedependent expansion of GFP-positive cells and viral DNA integration. These results suggested that the increase in viral antigen yield was caused by the release of a progeny virus following retro-transduction by the pseudotyped virus of the cells within the transfected cell culture. The infectivity as well as the amount of VSV-G on virus particles per unit of viral antigen was significantly different before and after the onset of the yield enhancement. This suggests that results of infection assays of the virus pseudotyped with VSV-G may be affected by the occurrence of such enhancement. This means that, while pseudotyping with VSV-G is a simple and effective method, this procedure should be carefully considered when the virus is produced for infectivity assays.
Introduction
Gene delivery using retroviral vectors has become a very popular and indispensable method. To ensure safety of the vectors and to increase their efficiency, envelope pseudotyping of viral vectors lacking their own envelope gene is used in almost all cases. Glycoprotein of vesicular stomatitis virus (VSV-G) in particular is one of the most frequently used envelope proteins for pseudotyping since it is very stable and promises highly effective and broad-spectrum gene delivery. However, there seems to be very little awareness of its adverse effect, that is, re-infection/retro-transduction. VSV-G interacts with a phospholipid component of the cell surface membrane and mediates viral entry by membrane fusion (Burns et al., 1993; Mastromarino et al., 1987) . As viral entry does not seem to require specific protein receptors, VSV-G pseudotyped vectors could infect virtually all kinds of cells. Thus, the VSV-G pseudotyped viral vector has the potential to infect its producer cells to re-generate progenies, which may contain unexpected characteristics. In the study presented here, we examined retro-transduction of VSV-G pseudotyped HIV-1 vectors. Our findings suggest that this problem could confound the interpretation of the experimental results under certain conditions and must therefore be taken into careful consideration.
Results

Enhancement of virion production by VSV-G pseudotyping
We previously noticed that the viral antigen yield of VSV-G pseudotyped HIV-1 by transfection was always much higher than that of the non-pseudotyped virus. We first reconfirmed this phenomenon by using a simplified experimental design. For this purpose, 2.5 μg of HIV-1 proviral plasmid pNLNh, which lacks Env expression, was transfected into 3 × 10 6 293T cells along with 2.5 μg of either pCG-VSVG, which expresses VSV-G under the CAG hybrid promoter (Niwa et al., 1991) , or pGEM-5Zf(+) (Promega, Madison, WI) as a control. The quantity of virus production was monitored by measuring CAp24 antigen in the culture supernatant every 12 h. The amounts of CA-p24 detected in VSV-G pseudotyped virus and in control were almost equal up to 24 h post-transfection. However, CAp24 production of the former became 10 times higher than that of control at 36 h and finally 20 times higher at 48 h (Fig. 1A) .
The actual amount of CA-p24 of virus from 3 × 10 6 of transfected cells with pseudotyping was typically 20-40 μg in total. This enhancement may have been caused by some transactivation effects of VSV-G, or by retro-transduction of the cells within the transfected cell culture, which then leads to production of the progeny virus. The absence of the enhancement at 12 or 24 h post-transfection suggests that transactivation was unlikely since the transactivation effect should become apparent from the onset of protein expression. In subsequent experiments, we therefore examined the possibility of retrotransduction of virus thus produced.
Retro-transduction of pseudotyped virus during transfection
The transfected cells were harvested 48 h post-transfection and viral antigens within the cells were detected by western blotting (Fig. 1B) . The viral antigens within cells producing the env-lacking virus were mostly large, seemingly uncleaved, and with the precursor protein Gag-Pr55 dominant. On the other hand, the protein profile within the cells producing the VSV-G pseudotyped virus was strikingly different. The majority of viral antigens were mature proteins, such as CA-p24 and MA-p17, while the number of immature proteins was very limited. This observation was in agreement with a hypothesis that the viral antigen within cells producing the pseudotyped virus mainly came from mature virions, which would support the concept of retro-transduction of the released virus.
To examine this possibility, a pol mutant pNLN-RI was constructed from pNLNh. The mutant had a large deletion at the RT and IN genes in addition to an Env frameshift, while the expression of functional Env, RT, and IN was eliminated. The VSV-G pseudotyped NLN-RI was therefore not able to complete retro-transduction to produce its progeny. Next, 293T cells were co-transfected with pNLN-RI along with either pCG-VSVG or pGEM-5Zf(+), and the quantity of virus production was monitored by measuring CA-p24. No difference in virus production was observed between VSV-G pseudotyped and non-pseudotyped viruses during 48 h post-transfection (Fig.  1C) . This indicates that the enhancement of virus production was impaired by the elimination of RT expression and subsequent inhibition of retro-transduction. 
Effect of viral enzyme inhibitors and fusion defective mutation to retro-transduction
To further test our hypothesis, two more experiments were performed. First, 293T cells were co-transfected with pNLNh and pCG-VSVG in the presence or absence of viral enzyme inhibitors. We used an effective RT inhibitor AZT (Mitsuya et al., 1985) and a protease inhibitor Ritonavir (Markowitz et al., 1995) (Fig. 2) . For efficient functioning of AZT, the amount of plasmid DNAs used in AZT experiment was reduced to 0.5 μg in total, and the day after transfection, the medium was replaced with fresh medium with or without the inhibitors. The amounts of virus production were measured 48 h post-transfection. When 0.5 μg of DNA was transfected into 3 × 10 6 cells, actual amount of CA-p24 of pseudotyped virus was typically 1-2 μg. Virion production was reduced to the same level as that of control in the presence of 5 μM AZT, and the enhancement was recovered as the concentration of the drug was reduced ( Fig.  2A) . The effect of Ritonavir was similar to that of AZT since 0.417 μM or more Ritonavir severely blocked the enhancement of virion production measured by pr55-Gag amounts (Fig. 2B) . For the second experiment, two VSV-G fusion defective mutants, pCGVG-G124E and pCGVG-P127D, were constructed. Both mutants contain one amino acid substitution at the fusion domain of the protein and reportedly lose their membrane fusion activity although their expression level at cell surface remains similar to that of the wild-type (Fredericksen and Whitt, 1995) . The mutants were compared to the wild-type VSV-G (WT-G) in terms of viral production enhancement by pseudotyping (Fig. 3A) . Both of the mutants showed very similar effects. Unexpectedly, the amount of virus production by the mutants was reduced throughout by approximately half compared to that by the non-pseudotyped virus. Nonetheless, the time course of virus production kinetics was almost identical for the mutants-pseudotyped and non-pseudotyped virus and drastically different from that of WT-G. Some of the data may 293T cells were co-transfected with 2.5 μg of pNLNh and 2.5 μg of either pCG-VSVG or pGEM-5Zf(+) in the absence or presence of 0.417 or 1.37 μM Ritonavir. Western blotting of released virion was performed and viral antigen was detected by anti-HIV-1 p24-CA monoclonal antibody. A series of dilution controls was generated (not shown), and the amount of Pr55-Gag were measured. The value for a sample with pseudotyping with 1.37 μM Ritonavir was set at 1. The amount of CA-p24 in the samples was efficiently reduced by the effect of Ritonavir. Results show the representative data of two independent experiments with similar results. be due to reduced virion production in the absence of a suitable envelope. To verify this possibility, we tried pseudotyping of envelope protein (Env) of HIV-2, which is a closely related virus of HIV-1. As the CD4 antigen, the cell surface receptor for HIV-1 and 2 (McClure et al., 1987) , is not expressed on the surface of non-lymphocyte cells such as 293T, virion pseudotyped with HIV-2 Env is noninfectious to 293T cells. The data of HIV-2 Env pseudotyping were very similar to that of the fusion defective mutants of VSV-G (Fig. 3B) , suggesting that envelope suitability does not affect virion production. HIV-2 Env pseudotyping was confirmed by infectivity assay. The infectivity of it per viral antigen was comparable to that of VSV-G pseudotyped one, suggesting that HIV-2 Env was efficiently incorporated into HIV-1 virion (data not shown). These results are a clear indication that the viral production enhancement by VSV-G pseudotyping was completely eliminated by the blocking of viral infectivity to producer cells and suggest that the enhancement was caused by retro-transduction and subsequent replication of the virus.
The GFP virus experiment and detection of provirus integration
To gain direct evidence of the retro-transduction, we constructed pMSMnG, a derivative of pNL4-3 expressing the green fluorescent protein (GFP) instead of viral nef protein. The 293T cells were transfected with 0.25 μg of pMSMnG along with or without 0.25 μg of pCG-VSVG, and GFP expression and viral DNA integration of the cells were analyzed from 12 h to 96 or 72 h after transfection (Fig. 4) . The amount of GFPpositive cells was similar between with and without VSV-G expression until 24 h. After that, that of VSV-G positive sample was increased dramatically and reached nearly to 70% at 72 h whereas that of VSV-G negative ones was only slightly increased to 15% (Fig. 4A ). Viral DNA integration was much drastic. It was virtually not observed in VSV-G negative sample throughout the experiment, whereas in VSV-G positive sample, very large amount of viral DNA integration was detected later than 24 h post-transfection (Fig. 4B ). These data clearly indicated the occurrence of massive retro-transduction and subsequent progenitor production.
Reduction of viral infectivity by retro-transduction
Finally, we examined differences between 'early' and 'late' virus particles. The virion production of the WT-G pseudotyped virus 48 h post-transfection was enhanced up to 20 times compared to that of non-pseudotyped viruses, whereas no such difference was observed at 24 h. This implies that most of the pseudotyped viruses at 48 h can be assumed to have been the result of replication, which might have resulted in some characteristics different from those of the virion produced solely by transfection. To verify this possibility, we harvested the total virus at 24 h ('early') and 48 h ('late') post-transfection and measured the amounts of virus production by CA-p24 ELISA and VSV-G on virus by western blotting (Fig. 5) . When we calculated the ratio of VSV-G to CA-p24 at the two time points, we found that the VSV-G content of the 'early' virus was approximately 5 times higher than that of the 'late' virus. This indicates that, under certain conditions, the relative amount of VSV-G of the 'late' virus is drastically reduced compared to that of the 'early' virus particle. To determine the effect of this reduction on virus infectivity, a single-round infection assay using the M8166/H1luc reporter cell line (Nagao et al., 2004) was performed (Fig. 5C ). The actual value of infectivity of 'early' virus was typically 1.3 × 10 5 RLU/s CA-p24 μg. The infectivity of the 'early' virus per CA-p24 was nearly 4 times higher than that of the 'late' virus. This shows that the infectivity of the 'early' and 'late' viruses mostly depends on the amount of VSV-G per virion and therefore could alter dramatically under certain conditions.
Discussion
Retrovirus pseudotyping is one of the most commonly used methods for not only gene delivery, but also virological studies. Since transfection of cells with envelope and gag/pol expression vectors makes it easy to generate infectious particles, this method rarely causes concern. However, notable incidents are sometimes observed even in the case of common experiments. In the study reported here, we focused on the enhancement of HIV-1 production by VSV-G protein pseudotyping. In the first set of experiments, we observed up to 20-fold enhancement of viral production by VSV-G pseudotyping, with no enhancement occurring on or before 24 h post-transfection (Fig. 1A) . We therefore hypothesized the occurrence of retro-transduction of the virus produced and subsequent virion production. Altered viral antigen profiles in transfected cells with or without pseudotyping indicated the presence of mature viral proteins in the cells with pseudotyping, thus corroborating our hypothesis (Fig. 1B) . The experiment using the HIV-1 pol mutant also suggested a close correlation between enhancement and viral infectivity (Fig. 1C) . In the subsequent experiments, we eliminated the infectivity of the produced virions by viral enzyme inhibitors (Fig. 2) , fusion defective mutation in VSV-G, or HIV-2 Env (Fig. 3) . Both of the experiments resulted in loss of the enhancement. These data all strongly suggested that the retro-transduction of the produced virus by the transfectant resulted in the release of large quantities of progeny virions.
The virus production was reduced in the virus pseudotyped with VSV-G mutants and HIV-2 Env compared to that in control from 12 h to 48 h post-transfection (Fig. 3) . This was possibly due to overexpression of the genes by the CAG promoter since CAG promoter activity is very strong (Niwa et al., 1991) and may take away the transcription/translation factors from other promoters. Reduction of the viral protein was not observed in case of WT-G pseudotyping, probably because the reduction of viral expression offset the enhancement of viral production by WT-G at 12 h, while the enhancement became dominant after that.
The experiment using GFP-virus gained direct evidence for retro-transduction (Fig. 4) . From 24 h to 72 h post-transfection, the percentage of GFP-positive cells just doubled in nonpseudotyped sample, which might reflect the period required for maturation of GFP in cells. In contrast, the increase was more than eight times in VSV-G pseudotyped sample. The result of Alu-PCR experiment gave us more solid evidence. The amount of integrated viral DNA was rapidly increased after 24 h posttransfection and reached more than 200-fold higher than the background levels from 24 h to 72 h post-transfection (Fig. 4B) . As the viral DNA integration was not detected in nonpseudotyped sample, this result directly demonstrated retrotransduction by pseudotyping during transfection.
The final experiment produced a striking result in terms of alteration of viral envelope incorporation and infectivity (Fig.  5 ). There was a more than 80% reduction in the quantity of VSV-G per virus at 48 h post-transfection compared to that at 24 h. Moreover, the infectivity of the 'late' virus was reduced in parallel to one-fourth that of the 'early' virus. Throughout the experiments, we used the calcium phosphate method for DNA transfection (Aldovini and Walker, 1990) , which is very popular due to its low cost, ease of manipulation, and efficiency. Co-transfection of multiple vectors enables a cell to uptake multiple genes simultaneously, and it is known that, with this method, usually 10-50% of the cells take up the DNA and express the genes thus introduced (Ausubel et al., 1995) . In our experiment, we usually noted a transfection efficiency of 20% at most (data not shown). In other words, far more than half the numbers of cells within a dish remained untransfected. The VSV-G pseudotyped virus could equally retro-transduce both transfected and untransfected cells during a transfection experiment. The genome of the pseudotyped virion lacked its original env gene and many of the cells were untransfected and thus did not express VSV-G on their surface. As a result, the majority of the cells probably produced progeny virions without envelope proteins. This implies that the reduction of VSV-G per virion observed represents a vast increase in noninfectious particles and a relative decrease in the ratio of pseudotyped virions. As this ratio can vary greatly depending on the time and conditions during transfection, infection experiments using such a mixture of infectious and noninfectious viruses may sometimes produce inconsistent results.
The single-round replication assay involves another issue. To compare the infectivity of mutants to that of the wild-type virus, single-round replication assays of pseudotyped viruses are often performed. If the infectivity of the mutants is reduced, which is very likely, the quantity of noninfectious progeny virions from cells retro-transducted by the mutants pseudotyped with VSV-G would be reduced. As a result, the quantity of infectious virions pseudotyped with the VSV-G contained in the mutants could be much larger than that of the wild-type. In such a case, the infectivity of the mutant per viral antigen would be greatly overestimated and may produce a misleading interpretation of the results.
Construction of a helper-vector system with self-inactivating vector (Miyoshi et al., 1998) eliminates the possibility of reproducing noninfectious viruses, and thus can solve the problems concerned. Nonetheless, retro-transduction of the vector is bound to occur as a result of VSV-G pseudotyping, and retro-transduction of the vector by the vector producing cells might yield somewhat unexpected results such as increase of pseudo-transduction (Liu et al., 1996) .
In conclusion, we have demonstrated that retro-transduction of HIV-1 pseudotyped with VSV-G into 293T cells resulted in the enhancement of virus production during transfection. The quantity of infectious viruses pseudotyped by VSV-G to that of the total quantity of viruses is significantly different depending on whether or not the enhancement occurs. In a simple experiment, such as making gene transfer vectors by VSV-G pseudotyping, this issue should not matter much. However, when the harvested virus is used for assays relating to infectivity, there are certain problems that possibly cause misleading of the results. Although VSV-G pseudotyping is very easy and convenient, the conditions under which this procedure is used should be carefully considered.
Materials and methods
Constructs
Replication-competent HIV-1 proviral clone pNL4-3 (Adachi et al., 1986) was digested with NheI (position 7250), blunted with KOD DNA polymerase, and self-ligated with T4 DNA ligase for the construction of pNLNh. pNLNh thus carries a 4-base insertion mutation within the env region, and Env protein expression is abrogated. To construct pNLN-RI, the BalI fragment encoding a part of the pol gene (position 2619 to 4551) was removed from pNLNh. EGFP gene was amplified using pCMX-SAH/Y145F (Kallio et al., 1998 ) (a generous gift from Dr. Takao Masuda, Tokyo medical and dental university) as a template and primers (5′-GGATTTTGCTATAAGATGGT-GAGCAAGGGCG-3′/5′-CTCGAGTTACTTGTACAGCTC-3′), and a portion of the env gene of pNL4-3 was amplified using primers (5′-GTGCTGTTAACTTGCTCAATGCC-3′/5′-CGCCCTTGCTCACCATCTTATAGCAAAATCC-3′). Two fragments were purified, mixed, and amplified again with the second and third primers to generate a fragment including EGFP utilizing ATG codon of nef gene as its own start codon and obtaining XhoI site just downstream of its stop codon. The fragment was cloned into pGEM-T Easy (Promega) and verified its nucleotide sequence to make pGEMHnGX. The plasmid pMSMBA (McBride and Panganiban, 1996) , a derivative of pNL4-3, was digested with HpaI and XhoI, and the HpaI-XhoI fragment of pGEMHnGX including EGFP gene was inserted in the corresponding position to construct pMSMnG.
pCGVG-G124E and pCGVG-P127D were generated by replacing the 1123-bp XbaI-Acc65I fragment in pCG-VSVG (a generous gift from Prof. Hideo Iba, Institute of Medical Science, University of Tokyo) with the corresponding fragment carrying the G124E and P127D mutation, respectively. The 5′ part of G124E and P127D fragments were amplified using primer pairs 5′-GCTCTAGAGCCTCTGCTAAC-3′/5′-AGG-GAACTCTGGATTCAGC-3′ and 5′-GCTCTAGAGCCTCT-GCTAAC-3′/5′-TTTGATCAGGGAAGCCTG, respectively. The 3′ part of the G124E and P127D fragments was amplified using primers 5′-GCTGAATCCAGAGTTCCC-3′/5′-TAGGG-TACCATTGATTAT GGT-3′ and 5′ -CCAGGCTTC-CCTGATCAAA-3′/5′-TAGGGTACCATTGATTATGGT-3′, respectively. The total G124E fragment was amplified with primers 5′-GCTCTAGAGCCTCTGCTAAC-3′/5′-TAGGG-TACCATTGATTATGGT-3′ (underlined nucleotides represent XbaI and Acc65I restriction sites) using the 5′ and 3′ parts of G124E as templates. The total P127D fragment was amplified in the same way as described above. The env coding region of pGH123 (Shibata et al., 1990) , a molecular infectious clone of HIV-2, was amplified with primers (5′-GCCGCCATGTGTGG-TAAGAGTCTAC-3′/5′-CTACAAGTCGTAACCATCGTC-3′) to add kozak sequence at 5′ end. The amplified fragment was cloned into pGEM-T Easy to generate pGEMH2env, and the sequence was verified. The HIV-2 env expression vector pCGH2env was generated by replacing an EcoRI fragment of pCG-VSVG including whole VSV-G fragment with the EcoRI fragment of pGEMH2env including the env gene.
Cell culturing and transfection
293T cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum, penicillin, and streptomycin. The cells were transfected with the calcium phosphate method (Aldovini and Walker, 1990) using either pNLNh or pNLN-RI and either pGEM-5Zf(+), pCGH2env, pCG-VSVG, or its derivatives.
Virus purification
At 24 or 48 h after transfection, the culture supernatants of the transfected cells were centrifuged at 1570×g for 20 min at 4°C, and virus particles in the supernatants were pelleted by ultracentrifugation (151,000×g, 1 h) through a 20% sucrose cushion. The pelleted viruses were then resuspended in growth medium for infection experiment or lysed with lysis buffer (50 mM Tris-HCl-pH 7.5, 100 mM NaCl, 10 mM EDTA, 1% SDS) for western blotting or CA-p24 quantitation. CA-p24 antigen was quantified with an ELISA kit (ZeptoMetrix Corp., Buffalo, NY) according to the manufacturer's instructions.
Virus infection
At 24 and 48 h post-transfection, the resultant virion was purified and used for infection into M8166/H1luc cells (Nagao et al., 2004) , which contain integrated reporter DNA carrying HIV-1 long terminal repeat (LTR) and luciferase. Upon infection with HIV-1, HIV-1 LTR is activated along with the expression of viral transactivator Tat, and luciferase expression in cytoplasm is induced. For our study, the cells (1 × 10 6 ) were infected at 37°C with 300 μl of three serially diluted viruses. After 90 min, the cells were washed with PBS, added to 1.5 ml of media and cultured for 40 h at 37°C. The infected cells were then washed with PBS and lysed with 125 μl of Glo lysis buffer (Promega), and a 50 μl sample of each lysate was assayed for photon emission after the addition of 50 μl of Bright-Glo Reagent (Promega) with a microplate luminometer (Centro LB 960; Berthold Technologies, Bad Wildbad, Germany).
Western blotting analysis
The lysates from the pelleted virus particles and cell lysates were prepared as described previously (Willey et al., 1988) , while the proteins were resolved on SDS-4-12% polyacrylamide gels and then electrophoretically transferred to polyvinylidene difluoride membranes. ECL western blotting detection reagents (Nakalai Tesque, Kyoto, Japan) were used to detect VSV-G or HIV-1 antigen on the membranes. Briefly, the membranes were incubated for 1 h at room temperature with anti-VSV-G polyclonal antibody (Rockland Immunochemicals, Gilbertsville, PA), the serum of HIV-1 infected patients, or anti-HIV-1 CA-p24 monoclonal antibody (Advanced Biotechnologies Inc., Columbia, MD) and washed. They were then incubated for another 1 h with horseradish peroxidaseconjugated anti-rabbit or anti-human IgG (Vector Laboratories, Burlingame, CA), washed, and visualized by chemiluminescence with LAS-1000 (Fujifilm, Tokyo, Japan) according to the manufacturer's manual. The relative intensity of each band was quantified by digital image analysis using ImageGauge software (Fujifilm).
Cell cytometry analysis
The 293T cells were harvested, washed twice with PBS (−), and fixed by suspending in 1% formaldehyde-PBS(−). The fixed cells were analyzed by FACScan (Bekton Dickinson, Franklin Lakes, NJ) to measure the expression of GFP.
Genomic DNA preparation
Transfected cells were harvested at 12, 24, 48, and 72 h posttransfection, washed twice with PBS(−), and pelleted. GenElute mammalian genomic DNA miniprep kit (Sigma, St. Louis, MO) was used to extract total DNA of the cells. DNA was digested overnight with DpnI restriction enzyme at 37°C to eliminate contaminating plasmids which were methylated.
Alu PCR analysis
For integrated proviral DNA quantitation, a modified Alu-PCR method from a recent report (Brussel and Sonigo, 2003) was employed. In the first round of PCR, two outward-facing Alu primers that anneal within the conserved regions of the Alu repeat element were used together with an HIV-1 LTR specific primer (L-M667) to optimize the probability of amplifying an LTR sequence since Alu elements could be present in either orientation relative to the integrated provirus. L-M667 consisted of an HIV-1 LTR-specific sequence fused with a lambda phagespecific tag sequence at the 5′ end (Brussel and Sonigo, 2003) . For the second round of PCR (real-time PCR), a lambdaspecific primer (Lambda T) (Brussel and Sonigo, 2003) was used as a sense primer to detect only the amplified fragments in the first round of PCR, and a Taqman probe and an anti-sense primer were selected from the set for R/U5 DNA detection in the previous report (Julias et al., 2001) . Cycling conditions of the first round of PCR were 94°C for 3 min followed by 22 cycles of 94°C for 30 s, 66°C for 30 s, 70°C for 10 min, and then 72°C for 10 min (Ikeda et al., 2004) . Equal volume of DNA (0.15 μg) was applied for amplification. Ten-fold serially diluted DNA samples of 72 h post-transfection with VSV-G pseudotyping were employed as standards. Total amount of DNA in each standard was adjusted by adding total DNA of mock-transfected cells. The resultant PCR products were diluted 100-fold and subjected to real-time PCR using ABI7500 (Applied Biosystems, Foster City, CA).
